Global Cell Culture Media for Vaccine Market, by Media Type (Animal Free/Serum Free, Bovine Derived and Porcine Derived Cell Culture), by Application (Animal Vaccine and Human Vaccine), and by Region (Latin America, Europe, Asia Pacific, North America, Africa, and Middle East) was valued at US$ 1,235.5 million in 2017 and is projected to exhibit a CAGR of 7.7% over the forecast period (2018 – 2026). In 2017, the market was worth US$ 1,235.5 million, and it is expected to grow at a CAGR of 7.7% from 2018 to 2026.
Get Sample Report with Latest Insights @
https://www.coherentmarketinsights.com/insight/request-sample/2608
The major players are concentrating their efforts on research and development in order to provide unique research-grade items that will meet the needs of researchers. For example, in November 2017, Proliant Biologicals introduced Reagent Grade (Fatty Acid-Free) BSA from New Zealand. The product is made from healthy animals from New Zealand. Furthermore, the market is predicted to develop due to an increase in government attempts to avoid certain diseases and epidemics caused by vaccine-preventable diseases.
Furthermore, an increasing implementation of national immunization programs to give vaccination and raise awareness about the benefits of vaccination in combating lethal diseases with natural immunity among children and adults. For example, as part of an inter-agency government effort in 2015, the Centers for Disease Control and Prevention (CDC), the Food and Drug Administration (FDA), and the National Institutes of Health (NIH) collaborated with the US Department of Health and Human Services Biomedical Advanced Research and Development Authority (BARDA) to support the advanced development of new and better influenza vaccines.
To expand their product range, key market players are focusing on techniques such as mergers and acquisitions. For example, Merck KGaA, the parent company of Merck Millipore, purchased the U.S.-based life science corporation Sigma-Aldrich Corporation for US$ 17 billion in November 2015 through its U.S. subsidiary EMD Millipore. In the United States, a united company known as MilliporeSigma was founded, making Merck Millipore one of the top three companies in the worldwide life science sector.
Want to “ahead” with your competiors request a PDF Brochure with Latest Insights @
https://www.coherentmarketinsights.com/insight/request-pdf/2608
Because of the rising prevalence of infectious diseases, the growing number of government efforts, and the increasing availability of new bovine blood plasma derivatives, the global cell culture media for vaccine market is predicted to grow at a CAGR of 7.7% over the forecast period. The Fetal Calf Serum (FCS)-free database, for example, was established in August 2017 by Animal Free Research UK and the 3Rs-Centre Utrecht Life Sciences. Researchers can use the database to find serum-free media for certain cell types, assisting in the adoption of animal-free research media.
Due to increased use of cow derived serum products in biotechnology research, vaccine manufacture, cloning, and in vitro fertilization, the human vaccine sector is expected to dominate the cell culture media for vaccine market in 2018.
In 2018, the cell culture medium for vaccine market is expected to be dominated by bovine derived media, as manufacture of viral vaccines requires fetal bovine serum or other sera as a source of nutrition or growth media for virus growth.
Major players operating in the global cell culture media for vaccine market include HiMedia Laboratories, Thermo Fisher Scientific Inc., Merck KGaA, General Electric Company, Sartorius AG, Proliant, Inc., Bovogen Biologicals Pty. Ltd., Rocky Mountain Biologicals, Valley Biomedical, Moregate BioTech, Atlanta Biologicals, Creative-Biolabs, Life Technologies (India) Pvt Ltd., Axil Scientific Pte Ltd., Indian Immunologicals Limited, Serum Institute of India Pvt. Ltd., Sisco Research Laboratories Pvt. Ltd., and Valneva SE
Reasons to Purchase this Report
• Current and future of global Cell Culture Media for Vaccine market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Media Type
- Market Snippet, By Application
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Porter’s analysis
- PEST analysis
- Regulatory Scenario
- Key Developments
- Raw material analysis
- Supply chain analysis
- Market Dynamics
- Global Cell Culture Media for Vaccine Market, By Media Type, 2018 – 2026, (US$ Mn)
- Introduction
- Market Share Analysis, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, 2017 – 2026
- Segment Trends
- Bovine Derived
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Fetal bovine serum (FBS)
- Newborn Calf Serum (NBCS)
- Adult Bovine Serum (ABS)
- Bovine Serum Albumin (BSA)
- Bovine Calf Serum (BCS)
- Porcine Derived
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Animal free/Serum Free Cell Culture
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Introduction
- Global Cell Culture Media for Vaccine Market, By Application, 2018 – 2026, (US$ Mn)
- Introduction
- Market Share Analysis, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, 2017 – 2026
- Segment Trends
- Human Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Animal Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Introduction
- Global Cell Culture Media for Vaccine Market, By Region, 2018 – 2026, (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, For Regions, 2017–2026
- North America
- Market Size and Forecast, By Media Type, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Application, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Media Type, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Application, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Media Type, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Application, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Media Type, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Application, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Market Size and Forecast, By Media Type, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Application, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Media Type, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Application, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
- South Africa
- Central Africa
- North Africa
- Introduction
- Competitive Landscape
- Heat Map Analysis
- Company Profiles
- HiMedia Laboratories
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Thermo Fisher Scientific Inc.
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Merck KGaA
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- General Electric Company
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Sartorius AG
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Proliant, Inc.
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Bovogen Biologicals Pty. Ltd.
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Rocky Mountain Biologicals
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Valley Biomedical
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Moregate BioTech
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Atlanta Biologicals
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Creative-Biolabs
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Life Technologies (India) Pvt Ltd.
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Axil Scientific Pte Ltd.
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Indian Immunologicals Limited
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Serum Institute of India Pvt. Ltd.
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Valneva SE
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- HiMedia Laboratories
- Analyst Views
- Section
- References
- Research Methodology
- About us and Sales Contact
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837